Emerald Advisers, LLC Reata Pharmaceuticals Inc Transaction History

Emerald Advisers, LLC

$2.41 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$79.22 - $105.37 $196,069 - $260,790	2,475 Added 0.79%	317,096 $32.3 Million
Q1 2023 May 04, 2023	SELL	$30.85 - $93.17 $11.3 Million - $34 Million	-365,151 Reduced 53.72%	314,621 $28.6 Million
Q4 2022 Feb 03, 2023	BUY	$22.15 - $42.11 $3.13 Million - $5.96 Million	141,520 Added 26.29%	679,772 $25.8 Million
Q3 2022 Oct 25, 2022	BUY	$19.41 - $36.49 $4.89 Million - $9.2 Million	252,071 Added 88.08%	538,252 $13.5 Million
Q2 2022 Jul 29, 2022	BUY	$20.71 - $36.5 $317,587 - $559,727	15,335 Added 5.66%	286,181 $8.7 Million
Q1 2022 Apr 29, 2022	BUY	$24.12 - $39.6 $2.22 Million - $3.64 Million	91,974 Added 51.42%	270,846 $8.87 Million
Q4 2021 Feb 02, 2022	SELL	$25.61 - $110.96 $2.49 Million - $10.8 Million	-97,283 Reduced 35.23%	178,872 $4.72 Million
Q3 2021 Oct 28, 2021	BUY	$100.0 - $143.02 $2.97 Million - $4.25 Million	29,712 Added 12.06%	276,155 $27.8 Million
Q2 2021 Jul 29, 2021	SELL	$78.27 - $151.29 $1.18 Million - $2.27 Million	-15,024 Reduced 5.75%	246,443 $34.9 Million
Q1 2021 Apr 29, 2021	BUY	$94.25 - $132.81 $24.6 Million - $34.7 Million	261,467 New	261,467 $26.1 Million
Q3 2020 Oct 28, 2020	SELL	$93.53 - $163.34 $5.94 Million - $10.4 Million	-63,472 Closed	0 $0
Q2 2020 Jul 28, 2020	SELL	$126.3 - $176.56 $6.45 Million - $9.02 Million	-51,064 Reduced 44.58%	63,472 $9.9 Million
Q1 2020 Apr 30, 2020	BUY	$124.16 - $247.74 $1.54 Million - $3.08 Million	12,427 Added 12.17%	114,536 $16.5 Million
Q4 2019 Jan 29, 2020	SELL	$74.57 - $217.92 $13.5 Million - $39.4 Million	-180,709 Reduced 63.9%	102,109 $20.9 Million
Q3 2019 Oct 31, 2019	SELL	$71.26 - $95.75 $7.45 Million - $10 Million	-104,551 Reduced 26.99%	282,818 $22.7 Million
Q2 2019 Jul 31, 2019	SELL	$77.72 - $94.35 $366,838 - $445,332	-4,720 Reduced 1.2%	387,369 $36.5 Million
Q1 2019 May 01, 2019	SELL	$51.9 - $101.79 $4.07 Million - $7.97 Million	-78,342 Reduced 16.65%	392,089 $33.5 Million
Q4 2018 Jan 30, 2019	SELL	$48.76 - $76.44 $138,673 - $217,395	-2,844 Reduced 0.6%	470,431 $26.4 Million
Q3 2018 Oct 31, 2018	SELL	$35.64 - $92.06 $2.57 Million - $6.65 Million	-72,245 Reduced 13.24%	473,275 $38.7 Million
Q2 2018 Jul 31, 2018	BUY	$19.94 - $40.96 $1.03 Million - $2.12 Million	51,767 Added 10.48%	545,520 $19.1 Million
Q1 2018 Apr 26, 2018	SELL	$20.0 - $30.19 $1.36 Million - $2.05 Million	-67,983 Reduced 12.1%	493,753 $10.1 Million
Q4 2017 Feb 05, 2018	SELL	$22.39 - $33.27 $171,955 - $255,513	-7,680 Reduced 1.35%	561,736 $15.9 Million
Q3 2017 Oct 30, 2017	BUY	$26.29 - $31.88 $15 Million - $18.2 Million	569,416	569,416 $17.7 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account